A systematic immunohistochemical study of 3215 cases

American Journal of Surgical Pathology

Volumn 38, Issue 3, 2014, Pages 410-420

  Miettinen, Markku ^a   Wang, Zengfeng ^a   Mccue, Peter A ^b   Sarlomo Rikala, Maarit ^c   Rys, Janusz ^d   Biernat, Wojciech ^e   Lasota, Jerzy ^a   Lee, Yi Shan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

cholangiocarcinoma; gastric adenocarcinoma; germ cell tumor; immunohistochemistry; NANOG; OCT4; SALL4; serous carcinoma; small cell carcinoma; urothelial carcinoma

Indexed keywords

SALL4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; ARTICLE; BIOPSY; CANCER GRADING; CARCINOMA; CELL DIFFERENTIATION; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM; PATHOLOGY; PREDICTIVE VALUE;

ADULT; BIOPSY; CARCINOMA; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM GRADING; NEOPLASMS, GERM CELL AND EMBRYONAL; PREDICTIVE VALUE OF TESTS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894426988     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000116     Document Type: Article

References (29)

1. Yang J, Chai L, Fowles TC, et al. Genome-wide analysis reveals SALL4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc Natl Acad Sci USA. 2008;105:19756-19761
2. Zhang J, Tam WL, Tong GQ, et al. SALL4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol. 2006;8:1114- 1123
3. Wu Q, Chen X, Zhang J, et al. SALL4 interacts with nanog and cooccupies Nanog genomic sites in embryonic stem cells. J Biol Chem. 2006;281:24090-24094
4. Zhou Q, Chipperfield H, Melton DA, et al. A gene regulatory network in mouse embryonic stem cells. Proc Natl Acad Sci USA. 2007;104:16438-16443
5. Warren M, Wang W, Spiden S, et al. A SALL4 mutant mouse model useful for studying the role of SALL4 in early embryonic development and organogenesis. Genesis. 2007;45:51-58
6. Kohlhase J, Schubert L, Liebers M, et al. Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy. J Med Genet. 2003;40:473-478
7. Kohlhase J. SALL4-related disorders. InPagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, eds. GeneReviewst [Internet]. Seattle (WA): University of Washington, Seattle; 2004:1993-2013
8. Ma Y, Cui W, Yang J, et al. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood. 2006; 108:2726-2735
9. Kohlhase J, Heinrich M, Liebers M, et al. Cloning and expression analysis of SALL4, the murine homologue of the gene mutated in Okihiro syndrome. Cytogenet Genome Res. 2002;98:274-277
10. Cao D, Guo S, Allan RW, et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009;33:894-904
11. Cao D, Li J, Guo CC, et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol. 2009;33:1065-1077
12. Liu A, Cheng L, Du J, et al. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Am J Surg Pathol. 2010;34:697-706
13. Wang F, Liu A, Peng Y, et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: An immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol. 2009;33: 1529-1539
14. Cao D, Humphrey PA, Allan RW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer. 2009;115:2640-2651
15. Ushiku T, Shinozaki A, Shibahara J, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol. 2010;34:533-540
16. Kobayashi D, Kuribayashi K, Tanaka M, et al. Overexpression of SALL4 in lung cancer and its importance in cell proliferation. Oncol Rep. 2011;26:965-970
17. Forghanifard MM, Moghbeli M, Raeisossadati R, et al. Role of SALL4 in the progression and metastasis of colorectal cancer. J Biomed Sci. 2013;20:20-26
18. Miettinen M. A simple method for generating multitissue blocks without special equipment. Appl Immunohistochem Mol Morphol. 2012;20:410-412
19. Toyoda D, Taguchi A, Chiga M, et al. SALL4 is transiently expressed in the caudal Wolffian duct and the ureteric Bud, but dispensable for kidney development. PloS One. 2013;8:e68508
20. Korkava H, Wicha MS. HER2 and breast cancer stem cells: More than meets the eye. Cancer Res. 2013;73:3489-3493
21. Kobayashi D, Kuribayshi K, Tanaka M, et al. SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer. Int J Oncol. 2011;38:933-939
22. Ikeda H, Sato Y, Yoneda N, et al. a-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. Hum Pathol. 2012;43:1955-1963
23. Gonzalez-Roibon N, Katz B, Chaux A, et al. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. Hum Pathol. 2013;44:1293-1299
24. Deisch J, Raisanen J, Rakheja D. Immunoexpression of SALL4 in Wilms tumors and developing kidney. Pathol Oncol Res. 2011;17:639-644
25. Deisch J, Raisanen J, Rakheja D. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors. Pediatr Dev Pathol. 2011;14:353-359
26. Venneti S, Le P, Martinez D, et al. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins. Am J Surg Pathol. 2011;35:1463-1472
27. Esheba GE, Pate LL, Longacre TA. Ocofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Am J Surg Pathol. 2008;32:600-607
28. Maeda D, Ota S, Takazawa Y, et al. Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod Pathol. 2009;22:824-832
29. Cui W, Kong NR, Ma Y, et al. Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia. Mod Pathol. 2006;19:1585-1592